Medical and Pharmaceutical Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine Insilico has developed at least 28 drug candidates using generative AI tools Joseph Morton4 days ago
AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph MortonMarch 27, 2026
Medical and Pharmaceutical Mark Zuckerberg backs AI-biology project to predict, prevent, and treat disease When Biohub began its goal was to help scientists cure or prevent all diseases this century Joseph MortonNovember 7, 2025
AI and Autonomy The promises and perils of artificial intelligence: a Mugglehead roundup AI represents a dual-edged force with the capability of reordering society for good or for ill Joseph MortonOctober 31, 2025
AI and Autonomy Alibaba Group gets FDA nod for cancer detection tool The tool can effectively detect early-stage cancers in asymptomatic patients Joseph MortonApril 24, 2025
Health & Wellness Personalis Inc share price jumps 50% on deals with Merck and Moderna These developments are a validation of Personalis' business strategy and its potential in the genomics and cancer treatment space Joseph MortonDecember 19, 2024